Caffeine for Hypoxic-Ischemic Encephalopathy

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 14, 2019

Primary Completion Date

January 1, 2023

Study Completion Date

December 31, 2024

Conditions
Hypoxic-Ischemic Encephalopathy
Interventions
DRUG

Caffeine Citrate 5 mg/kg

Loading dose of caffeine 20 mg/kg IV followed by two daily doses of 5 mg/kg IV.

DRUG

Caffeine Citrate 10 mg/kg

Loading dose of caffeine 20 mg/kg IV followed by two daily doses of 10 mg/kg IV.

Trial Locations (1)

27599

The University of North Carolina at Chapel Hill Newborn Critical Care Center, Chapel Hill

All Listed Sponsors
collaborator

Thrasher Research Fund

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT03913221 - Caffeine for Hypoxic-Ischemic Encephalopathy | Biotech Hunter | Biotech Hunter